Cytek Corp (CTKB) Price to Earnings Ratio

Corporate emblem and logo of Cytek Bio (CTKB)

Sensor development costs for Cytek Biosciences, Inc. (CTKB) create risks visible through changes in the company's P/E ratio on this chart, where the parameter value is -9.60. While geopolitical barriers limit the export of cytometers, rising sales of multicolor systems and demand for reagents ensure steady revenue, supporting the asset's current market value.

CTKB Cytek Biosciences: Price to Earnings Ratio in the range 07/04/2022 - 11/10/2026

Analytical breakdowns for Cytek Biosciences, Inc.

- price and consensus price forecast:
Stock Price cytekbio.com|CTKB - Price Target Chart
- market capitalization details:
Market Value Cytek Biosciences, Inc.|CTKB - Real Price to Acquire Entire Company
- book capitalization information:
Net Asset Value per Share Cytek Biosciences|CTKB - Company Book Value|Market Capitalization to Book Value cytekbio.com|CTKB - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Cytek Biosciences, Inc.|CTKB - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Cytek Corp|CTKB - Company Aggregate Debts|Debt to Book Value Cytek Biosciences, Inc.|CTKB - Company Long-Term Liabilities|Short-Term Debt Cytek Biosciences|Intermediate Liquidity Ratio cytekbio.com
- business earnings and investment ratios data:
CTKB - Net Profit|Expected Net Profit Cytek Biosciences, Inc.|CTKB - Price to Earnings Ratio|Forward P/E Multiple Cytek Biosciences Inc|CTKB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Cytek Biosciences, Inc.|CTKB - Operating profit EBITDA|Earnings per share for the last twelve months Cytek Biosciences|CTKB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months cytekbio.com|CTKB - Earnings per share growth in current year|Expected net earnings per share growth next year Cytek Biosciences, Inc.
Summary company analysis:CTKB cytekbio.com
Manufactured product of Cytek Biosciences, Inc.

The market evaluates the potential of Cytek Biosciences, Inc. (CTKB) through the lens of its unique spectral profiling technology, determining the business value relative to generated cash flow. By analyzing the company's P/E chart, an investor can see the ratio of market capitalization to net income, which allows for determining the premium paid for innovation in cellular analysis and assessing the overall resilience of the asset.

Competing companies

P/E Multiple agilent.com|Price to Earnings Ratio Quest Diagnostics Incorporated (DGX)|Price to Earnings Ratio ILMN (Illumina Inc)|Cologuard - Price to Earnings Ratio|Revvity Corp (RVTY) - Market Cap to Earnings|BIO - Price to Earnings Ratio|Business Payback Period anbio.com NNNN|SHC: P/E Multiple|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Corp|caredx.com (CDNA) - Business Payback Period|P/E Multiple MRVI|Price to Earnings Ratio fulgentgenetics.com FLGT|Standard BioTools - Price to Earnings Ratio|OraSure Technologies, Inc. (OSUR) - Market Cap to Earnings|XGN: Price to Earnings Ratio|MDxHealth, Inc. - Market Price to Net Income Ratio|LUCD: P/E Multiple|Market Cap to Earnings Prenetics (PRE)|Price to Earnings Ratio Insight Molecular Diagnostics, Inc.|P/E Multiple Trinity Biotech Corp|Price to Earnings Ratio PRPH (ProPhase)|AIMD (Ainos Corporation) - Company Value to Net Income|P/E Multiple CODX (Co-Diagnostics, Inc.)|heartsciences.com - Price to Earnings Ratio|Biomerica - P/E Multiple|Business Payback Period Cardio Diagnostics CDIO|Onconetix Corp (ONCO) - Price to Earnings Ratio|Market Cap to Earnings Virax Biolabs Corp (VRAX)|Price to Earnings Ratio Bluejay Diagnostics|aspirawh.com (AWH) - Business Payback Period|P/E Multiple AXDX|Price to Earnings Ratio CENTOGENE CNTG|P/E Multiple ENZ (Enzo Biochem)|Business Payback Period Fresh2 Group Ltd (FRES)|GTG Labs - P/E Multiple|Market Cap to Earnings 23andme.com|Psychemedics Corporation (PMD) - Price to Earnings Ratio